(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...

Cancer.  For many, this word brings an instant sense of negativity.  Hearing the word cancer, whether in a personal context ...

Following almost a decade of decline, prostate cancer incidence in the U.S. increased 3.0% per year between 2014 through 2021, according to a report published Sept. 2 in CA: A Cancer Journal for ...

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

A new comprehensive review suggests that screening men for prostate cancer using a blood test could reduce deaths from the ...

The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...

Prostate cancer specialists oppose plans to restrict screening to only a few thousand men, research has shown.

ADT plus apalutamide before and after surgery significantly improved metastasis-free survi ...

The U.S. cancer death rate has hit a milestone: It's been falling for at least 25 years, according to a new report. Lower smoking rates are translating into fewer deaths. Advances in early detection ...